Shattuck Labs (STTK) Share-based Compensation (2019 - 2026)
Shattuck Labs (STTK) posted quarterly Share-based Compensation of $262000.0 for Q1 2026, down 84.78% year-over-year from $1.7 million in Q1 2025, and down 96.22% quarter-over-quarter from $6.9 million in Q4 2025.
Shattuck Labs (STTK) Share-based Compensation (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has reported Share-based Compensation for 8 consecutive years, with $262000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Share-based Compensation fell 84.78% year-over-year to $262000.0; the TTM figure through Mar 2026 stood at $5.5 million (up 1927.06% YoY), while the FY2025 annual figure was $7.0 million, up 1451.0% from the prior year.
- Share-based Compensation declined to $262000.0 in Q1 2026 per STTK's latest filing, from $6.9 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $7.2 million in Q3 2024 and bottomed at -$7.2 million in Q4 2024.
- Historically, Share-based Compensation has averaged $1.5 million across 5 years, with a median of $1.8 million in 2025.
- On a YoY basis, Share-based Compensation climbed as much as 6246.15% in 2024 and fell as far as 205.0% in 2024.
- Shattuck Labs' Share-based Compensation stood at $2.9 million in 2022, then surged by 134.3% to $6.9 million in 2023, then tumbled by 205.0% to -$7.2 million in 2024, then soared by 195.65% to $6.9 million in 2025, then plunged by 96.22% to $262000.0 in 2026.
- Business Quant data shows STTK's Share-based Compensation at $262000.0 in Q1 2026, $6.9 million in Q4 2025, and -$3.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 277.20 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 137.41 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 590,899.88 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 86.63 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 41.25 Mn |
| 10 | Shattuck Labs | 962.96 Mn | 962.96 Mn | - | 2.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.73 Mn |
| Jun 30, 2026 | 2.73 Mn |
| Mar 31, 2026 | 262,000.00 |
| Mar 31, 2026 | 262,000.00 |
| Dec 31, 2025 | 6.93 Mn |
| Dec 31, 2025 | 6.93 Mn |
| Sep 30, 2025 | -3.55 Mn |
| Sep 30, 2025 | -3.55 Mn |
| Jun 30, 2025 | 1.89 Mn |
| Jun 30, 2025 | 1.89 Mn |
| Mar 31, 2025 | 1.72 Mn |
| Mar 31, 2025 | 1.72 Mn |
| Dec 31, 2024 | -7.25 Mn |
| Dec 31, 2024 | -7.25 Mn |
| Sep 30, 2024 | 7.25 Mn |
| Sep 30, 2024 | 7.25 Mn |
| Jun 30, 2024 | -2.03 Mn |
| Jun 30, 2024 | -2.03 Mn |
| Mar 31, 2024 | 2.48 Mn |
| Mar 31, 2024 | 2.48 Mn |